CJC-1295 + Ipamorelin Side Effects: What Each Trial Found, What Users Report, and What the Stack Adds

Written by Dr. Andrii Kaleniuk. Updated October 25, 2026.

The CJC-1295 and ipamorelin stack has never been tested together in a clinical trial, so its side effects have to be pieced together from the two drugs' separate, short histories: CJC-1295's single published human study, in which healthy adults had flushing, headache and injection-site reactions while growth hormone stayed elevated for a week; ipamorelin's one-week hospital trial, where it was as well tolerated as placebo; and the long record of what sustained growth hormone does to the body, which is where the real risks of the combination sit. Neither peptide is approved anywhere, both are prohibited in sport, and the products sold for the stack are unverified.

This guide separates what is documented for each component from what users report, explains why the long-acting DAC version of CJC-1295 changes the risk profile, lays out the growth-hormone-related effects that the stack can amplify, and covers who should avoid it. It does not include dosing: no safe dose for this combination has been established.

CJC-1295 is a modified version of growth-hormone-releasing hormone (GHRH), the signal from the hypothalamus that tells the pituitary to release growth hormone. The version most sold, CJC-1295 with DAC, carries a chemical tag that binds it to albumin in the blood, stretching its half-life from minutes to about six to eight days, so GH stays elevated continuously rather than in pulses. Ipamorelin acts on a different receptor, the ghrelin receptor (GHS-R1a), to trigger a pulse of GH without the cortisol and hunger surge that older peptides like GHRP-6 cause. Stacking a GHRH analogue with a ghrelin mimetic produces more GH than either alone, which is the whole rationale, and is also why the side-effect profile is not simply the sum of two mild lists. The muscle claims are examined in CJC-1295 + ipamorelin for muscle growth.

Two points follow. First, both drugs looked tolerable in short studies, which is the basis of the "safe" reputation. Second, nobody has studied what bodybuilders actually do with them: weekly or daily injections for months, often alongside other substances. The ipamorelin side effects guide covers the single-peptide data in more depth.

These come from forums, clinic FAQs and vendor pages. They cannot show frequency or causation, and some may reflect what else was in the vial, but the same complaints recur:

CJC-1295 without DAC (sometimes sold as modified GRF 1-29) lasts about 30 minutes and produces a GH pulse close to the body's own pattern. CJC-1295 with DAC keeps GH and IGF-1 elevated around the clock for a week or more. Continuous rather than pulsatile GH exposure is what the body sees in acromegaly, and it is the pattern most associated with fluid retention, insulin resistance, joint symptoms and tissue growth. Most "CJC-1295/ipamorelin" products use the DAC form because it is more potent per injection, which means the stack as usually sold delivers the more continuous, higher-risk exposure. We go through the GH-versus-muscle evidence in CJC-1295 for muscle growth.

Almost all CJC-1295 and ipamorelin used outside a clinic comes from online vendors labeled "for research use only," and some from compounding pharmacies. FDA has placed both peptides in Category 2 of its bulk substances list for outsourcing facilities, meaning substances that may present significant safety risks, citing limited safety data and concerns about immunogenicity (immune reactions to peptide impurities). Independent testing of research peptides has repeatedly found underdosed, mislabeled and contaminated products. For an injectable, that adds infection, bacterial toxins and immune reactions to the list, and it means some of the side effects attributed to the stack may be reactions to impurities rather than to the peptides.

Taken separately, CJC-1295 and ipamorelin each have a week or a few weeks of human safety data showing mostly mild effects: flushing, headache, injection-site reactions, a dip in blood pressure. Taken together, as a DAC stack over months, they produce the kind of continuous growth hormone elevation that is known to cause fluid retention, nerve compression, higher blood sugar and, in theory, tissue growth, and nobody has measured how often. Add unverified products and the absence of any approval, and the honest summary is that the stack's side effects are probably mild for most people in the short term and unknown for everyone in the long term. For how these peptides compare with the one approved option in the class, see tesamorelin vs ipamorelin and tesamorelin vs CJC-1295 vs ipamorelin; for the "gentler" alternatives people consider, sermorelin vs ipamorelin.

This article is for information only. It is not medical advice and does not recommend using these peptides. Talk to a doctor before using any unapproved substance.